Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence

Pediatric Transplantation

Volumn 16, Issue 7, 2012, Pages

  Chikamoto, Hiroko ^a   Hattori, Motoshi ^a   Kuroda, Nao ^a   Kajiho, Yuko ^a   Matsumura, Hideki ^a   Fujii, Hiroshi ^a   Ishizuka, Kiyonobu ^a   Hisano, Masataka ^a   Akioka, Yuko ^a   Nozu, Kandai ^b   Kaito, Hiroshi ^b   Shimizu, Maki ^c  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TAKAMATSU RED CROSS HOSPITAL   (Japan)

Author keywords

children; focal segmental glomerulosclerosis; plasmapheresis; post transplantation recurrence; prophylactic therapy; rituximab

Indexed keywords

ALBUMIN; BASILIXIMAB; CD19 ANTIGEN; CREATININE; CYCLOSPORIN; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS;

ARTICLE; CASE REPORT; CHILD; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIALYSIS; FEMALE; FOCAL GLOMERULOSCLEROSIS; GRAFT FAILURE; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVING DONOR; NEPHRECTOMY; PLASMAPHERESIS; POSTOPERATIVE CARE; PROTEINURIA; RECURRENT DISEASE; SCHOOL CHILD; TREATMENT FAILURE;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CHILD; DISEASE PROGRESSION; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT SURVIVAL; HUMANS; IMMUNOLOGIC FACTORS; KIDNEY TRANSPLANTATION; LIVING DONORS; PLASMAPHERESIS; RECURRENCE; RENAL INSUFFICIENCY; REOPERATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84866730915     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01610.x     Document Type: Article

References (22)

1. Vinai M, Waber P, Seikaly MG,. Recurrence of focal segmental glomerulosclerosis in renal allograft: An in-depth review. Pediatr Transplant 2010: 14: 314-325.
2. Ponticelli C, Glassock RJ,. Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol 2010: 5: 2363-2372.
3. Fine RN,. Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr Nephrol 2007: 22: 496-502.
4. Ponticelli C,. Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation. Nephrol Dial Transplant 2010: 25: 25-31.
5. Gohh RY, Yango AF, Morrissey PE, et al., Preemptive plasmapheresis and recurrence of FSGS in high-risk transplant recipients. Am J Transplant 2005: 5: 2907-2912.
6. Pescovitz MD, Book BK, Sidner RA,. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 2006: 354: 1961-1963.
7. Hristea D, Hadaya K, Marangon N, et al., Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasamapheresis and rituximab. Transpl Int 2007: 20: 102-105.
8. Furue T, Hattori M, Tsukaguchi H, et al., Clinical features and mutational survey of NPHS2 (podocin) in Japanese children with focal segmental glomerulosclerosis who underwent renal transplantation. Pediatr Transplant 2008: 12: 341-346.
9. Hattori M, Akioka Y, Chikamoto H, et al., Increase of integrin-linked kinase activity in cultured podocytes upon stimulation with plasma from patients with recurrent FSGS. Am J Transplant 2008: 8: 1550-1556.
10. Ohta T, Kawaguchi H, Hattori M, et al., Effect of pre- and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation 2001: 71: 628-633.
11. Ljungman P, Griffiths P, Paya C,. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002: 34: 1094-1097.
12. Cochat P, Fargue S, Mestrallet G, et al., Disease recurrence in paediatric renal transplantation. Pediatr Nephrol 2009: 24: 2097-2108.
13. Benoit G, Machuca E, Antignac C,. Hereditary nephrotic syndrome: A systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol 2010: 25: 1621-1632.
14. Baum MA, Stablein DM, Panzarino VM, Tejani A, Harmon WE, Alexander SR,. Loss of living donor renal allograft advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001: 59: 328-333.
15. Takahashi K, Saito K, Takahara S, et al., Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004: 4: 1089-1096.
16. Hickson LJ, Gera M, Amer H, et al., Kidney transplantation for primary focal segmental glomerulosclerosis: Outcomes and response to therapy for recurrence. Transplantation 2009: 87: 1232-1239.
17. Tydén G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I,. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005: 5: 145-148.
18. Faul C, Donnelly M, Merscher-Gomez S, et al., The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008: 14: 931-938.
19. Rianthavorn P, Bhakta N, Gjertson DW, Ettenger RB,. A coherent approach to recurrent focal segmental glomerulosclerosis in children? The effects of high dose cyclosporine and pretransplant plasmapheresis. Pediatr Transplant 2005: 9 (Suppl 6): 48.
20. Kamar N, Milioto O, Puissant-Lubrano B, et al., Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients. Am J Transplant 2010: 10: 89-98.
21. Yabu JM, Ho B, Scandling JD, Vincenti F,. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant 2008: 8: 222-227.
22. Strologo LD, Guzzo I, Laurenzi C, et al., Use of rituximab in focal glomerulosclerosis relapses after renal transplantation. Transplantation 2009: 88: 417-420.